Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Last reviewed: 18 Sept 2024 Accessing Wegovy for weight loss: Everything you need to know (2023) Department of Health and Social Care Media Centre [accessed August 2024] Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis* (2022) NIH [accessed August 2024] Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials (2022) Frontiers [accessed August 2024] NICE recommends new drug for people living with obesity (2022) NICE [accessed August 2024] Mounjaro KwikPen 10mg solution for injection in pre-filled pen (2024) EMC [accessed August 2024] Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021) NEJM [accessed August 2024] Saxenda 6mg/mL solution for injection in pre-filled pen (2023) EMC [accessed August 2024] Semaglutide and pregnancy (2023) Wiley Obstetrics and Gynaecology Online Library [accessed August 2024] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen (SmPC) emc [accessed 13 January 2025] Our doctors are regulated by the CQC and GPhC, the same bodies overseeing NHS care.
An Overview of Ozempic Ozempic is a medication containing the active ingredient semaglutide and is approved by the FDA for use in managing type 2 diabetes
It is not the approved SCENESSE (afamelanotide) implant drug product and is not intended, manufactured, tested, or released for human or veterinary administration
late cancellations and no-shows will be charged a $50 rebooking fee
How much precision do I need
US$ 26.81
US$ 27.60
US$ 20.01
US$ 20.62
